These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

390 related articles for article (PubMed ID: 23023701)

  • 1. Intrahepatic cholangiocarcinoma can arise from Notch-mediated conversion of hepatocytes.
    Sekiya S; Suzuki A
    J Clin Invest; 2012 Nov; 122(11):3914-8. PubMed ID: 23023701
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Kupffer cells induce Notch-mediated hepatocyte conversion in a common mouse model of intrahepatic cholangiocarcinoma.
    Terada M; Horisawa K; Miura S; Takashima Y; Ohkawa Y; Sekiya S; Matsuda-Ito K; Suzuki A
    Sci Rep; 2016 Oct; 6():34691. PubMed ID: 27698452
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cell lineage tracing reveals a biliary origin of intrahepatic cholangiocarcinoma.
    Guest RV; Boulter L; Kendall TJ; Minnis-Lyons SE; Walker R; Wigmore SJ; Sansom OJ; Forbes SJ
    Cancer Res; 2014 Feb; 74(4):1005-10. PubMed ID: 24310400
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Notch2 controls hepatocyte-derived cholangiocarcinoma formation in mice.
    Wang J; Dong M; Xu Z; Song X; Zhang S; Qiao Y; Che L; Gordan J; Hu K; Liu Y; Calvisi DF; Chen X
    Oncogene; 2018 Jun; 37(24):3229-3242. PubMed ID: 29545603
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cholangiocarcinomas can originate from hepatocytes in mice.
    Fan B; Malato Y; Calvisi DF; Naqvi S; Razumilava N; Ribback S; Gores GJ; Dombrowski F; Evert M; Chen X; Willenbring H
    J Clin Invest; 2012 Aug; 122(8):2911-5. PubMed ID: 22797301
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Induction of differentiation of intrahepatic cholangiocarcinoma cells to functional hepatocytes using an organoid culture system.
    Saito Y; Nakaoka T; Muramatsu T; Ojima H; Sukeda A; Sugiyama Y; Uchida R; Furukawa R; Kitahara A; Sato T; Kanai Y; Saito H
    Sci Rep; 2018 Feb; 8(1):2821. PubMed ID: 29434290
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oncogenic potential of IDH1R132C mutant in cholangiocarcinoma development in mice.
    Ding N; Che L; Li XL; Liu Y; Jiang LJ; Fan B; Tao JY; Chen X; Ji JF
    World J Gastroenterol; 2016 Feb; 22(6):2071-80. PubMed ID: 26877611
    [TBL] [Abstract][Full Text] [Related]  

  • 8.
    Matsumori T; Kodama Y; Takai A; Shiokawa M; Nishikawa Y; Matsumoto T; Takeda H; Marui S; Okada H; Hirano T; Kuwada T; Sogabe Y; Kakiuchi N; Tomono T; Mima A; Morita T; Ueda T; Tsuda M; Yamauchi Y; Kuriyama K; Sakuma Y; Ota Y; Maruno T; Uza N; Marusawa H; Kageyama R; Chiba T; Seno H
    Cancer Res; 2020 Dec; 80(23):5305-5316. PubMed ID: 33067264
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Insights into the role of STAT3 in intrahepatic cholangiocarcinoma (Review).
    Yang R; Song Y; Shakoor K; Yi W; Peng C; Liu S
    Mol Med Rep; 2022 May; 25(5):. PubMed ID: 35302174
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A novel mouse model of intrahepatic cholangiocarcinoma induced by liver-specific Kras activation and Pten deletion.
    Ikenoue T; Terakado Y; Nakagawa H; Hikiba Y; Fujii T; Matsubara D; Noguchi R; Zhu C; Yamamoto K; Kudo Y; Asaoka Y; Yamaguchi K; Ijichi H; Tateishi K; Fukushima N; Maeda S; Koike K; Furukawa Y
    Sci Rep; 2016 Apr; 6():23899. PubMed ID: 27032374
    [TBL] [Abstract][Full Text] [Related]  

  • 11.
    Hill MA; Alexander WB; Guo B; Kato Y; Patra K; O'Dell MR; McCall MN; Whitney-Miller CL; Bardeesy N; Hezel AF
    Cancer Res; 2018 Aug; 78(16):4445-4451. PubMed ID: 29871934
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hepatitis B virus-related intrahepatic cholangiocarcinoma originates from hepatocytes.
    Song Z; Lin S; Wu X; Ren X; Wu Y; Wen H; Qian B; Lin H; Huang Y; Zhao C; Wang N; Huang Y; Peng B; Li X; Peng H; Shen S
    Hepatol Int; 2023 Oct; 17(5):1300-1317. PubMed ID: 37368186
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oncogenic driver genes and tumor microenvironment determine the type of liver cancer.
    Wang G; Wang Q; Liang N; Xue H; Yang T; Chen X; Qiu Z; Zeng C; Sun T; Yuan W; Liu C; Chen Z; He X
    Cell Death Dis; 2020 May; 11(5):313. PubMed ID: 32366840
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inactivation of p120 catenin in mice disturbs intrahepatic bile duct development and aggravates liver carcinogenesis.
    van Hengel J; Van den Broeke C; Pieters T; Libbrecht L; Hofmann I; van Roy F
    Eur J Cell Biol; 2016 Dec; 95(12):574-584. PubMed ID: 27769530
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Liver stem cells: implications for hepatocarcinogenesis.
    Alison MR
    Stem Cell Rev; 2005; 1(3):253-60. PubMed ID: 17142862
    [TBL] [Abstract][Full Text] [Related]  

  • 16. TNF receptor-related factor 3 inactivation promotes the development of intrahepatic cholangiocarcinoma through NF-κB-inducing kinase-mediated hepatocyte transdifferentiation.
    Shiode Y; Kodama T; Shigeno S; Murai K; Tanaka S; Newberg JY; Kondo J; Kobayashi S; Yamada R; Hikita H; Sakamori R; Suemizu H; Tatsumi T; Eguchi H; Jenkins NA; Copeland NG; Takehara T
    Hepatology; 2023 Feb; 77(2):395-410. PubMed ID: 34995376
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mechanisms of biliary carcinogenesis and growth.
    Wise C; Pilanthananond M; Perry BF; Alpini G; McNeal M; Glaser SS
    World J Gastroenterol; 2008 May; 14(19):2986-9. PubMed ID: 18494047
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Liver cancer: Intrahepatic cholangiocarcinoma--appearances can be deceiving.
    Alison MR; Lin WR
    Nat Rev Gastroenterol Hepatol; 2013 Mar; 10(3):131-3. PubMed ID: 23318263
    [No Abstract]   [Full Text] [Related]  

  • 19. Intrahepatic cholangiocarcinoma arising in chronic advanced liver disease and the cholangiocarcinomatous component of hepatocellular cholangiocarcinoma share common phenotypes and cholangiocarcinogenesis.
    Xu J; Sasaki M; Harada K; Sato Y; Ikeda H; Kim JH; Yu E; Nakanuma Y
    Histopathology; 2011 Dec; 59(6):1090-9. PubMed ID: 22175889
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multiple cellular origins and molecular evolution of intrahepatic cholangiocarcinoma.
    Wei M; Lü L; Lin P; Chen Z; Quan Z; Tang Z
    Cancer Lett; 2016 Sep; 379(2):253-61. PubMed ID: 26940139
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.